IL10 and neoplasm: By using samples obtained from tumor-bearing Vert-X mice after a single treatment cycle, we confirmed that addition of gemcitabine to vaccination decreased the number of DC-IL-10+, not only in the spleen but also in tumor-draining lymph nodes (Supplementary Figure S6).